AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2025

Feb 20, 2025

32130_dirs_2025-02-20_7052b340-52a7-4f68-93d2-c26da9e287a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2025-02-18

Reporting Person: MacDonald Kelly (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-18	Common Stock	M	15477	—	Acquired	34202	Direct
2025-02-18	Common Stock	F	4975	$12.93	Disposed	29227	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-18	Restricted Stock Unit	$	M	15477	Disposed		Common Stock (15477)	Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual
anniversary of February 15, 2024.

F2: Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.